title: [Hyperlipemias and their manifestations in the rheumatological sphere].
abstract: It is fairly frequent to encounter hyperlipemia on a rheumatic unit. Firstly the symptoms of certain idiopathic hyperlipemias sometimes include rheumatic changes. The latter include firstly, arthritis and tendinitis, above all observed in Type II hyperlipoproteinemia but also mentionned in Type IV, and secondly, exceptional bony lesions (generally of xanthoma type) which seem to occur exclusively in severe hyperglyceridemia. A few bone and joint diseases, such as gout or aseptic necrosis, frequently coexist with dyslipemia. Furthermore, various diseases may be simultaneously responsible for secondary hyperlipemia and involvement of the locomotor apparatus. Finally, the iatrogenic manifestations of the locomotor system appear mainly due to hypolipemic drugs, e.g. the muscle disorders seen in a few patients treated with clofibrate.
mesh_terms: D000308:Adrenocortical Hyperfunction / Q000150:complications; D001168:Arthritis / Q000209:etiology*; D001847:Bone Diseases / Q000209:etiology*; D002994:Clofibrate / Q000009:adverse effects; D004387:Dupuytren Contracture / Q000150:complications; D006073:Gout / Q000150:complications; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications* / Q000235:genetics; D000960:Hypolipidemic Agents / Q000009:adverse effects; D007049:Iatrogenic Disease; D008180:Lupus Erythematosus, Systemic / Q000209:etiology; D009101:Multiple Myeloma / Q000209:etiology; D009135:Muscular Diseases / Q000209:etiology*; D009539:Nicotinic Acids / Q000009:adverse effects; D010020:Osteonecrosis / Q000150:complications; D012019:Reflex Sympathetic Dystrophy / Q000150:complications; D052256:Tendinopathy / Q000209:etiology; D014973:Xanthomatosis / Q000209:etiology*
chemical_list: D000960:Hypolipidemic Agents; D009539:Nicotinic Acids; D002994:Clofibrate
vernacular_title: Hyperlipidémies et manifestations de la sphère rhumatologique